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Abstract: Plasmodium falciparum malaria causes 500
million clinical cases with approximately one million
deaths each year. After many years of exposure,
individuals living in endemic areas develop a form of
clinical immunity to disease known as premunition, which
is characterised by low parasite burdens rather than
sterilising immunity. The reason why malaria parasites
persist under a state of premunition is unknown but it has
been suggested that suppression of protective immunity
might be a mechanism leading to parasite persistence.
Although acquired immunity limits the clinical impact of
infection and provides protection against parasite repli-
cation, experimental evidence indicates that cell-mediat-
ed immune responses also result in detrimental inflam-
mation and contribute to the aetiology of severe disease.
Thus, an appropriate regulatory balance between protec-
tive immune responses and immune-mediated pathology
is required for a favourable outcome of infection. As
natural regulatory T (Treg) cells are identified as an
immunosuppressive lineage able to modulate the mag-
nitude of effector responses, several studies have
investigated whether this cell population plays a role in
balancing protective immunity and pathogenesis during
malaria. The main findings to date are summarised in this
review and the implication for the induction of patho-
genesis and immunity to malaria is discussed.
Natural Regulatory T Cells
Control of infection is the main function of the immune system.
Some pathogens are difficult to eradicate and require a potent
immune response involving destructive and cytotoxic mediators,
which can result in adverse effects and immunopathology.
Lymphoid populations exerting immunosuppressive activity, such
as natural regulatory T (Treg) cells, have been shown to play a
critical role in balancing protective immune responses and
immune-mediated pathology [1–4]. This suppressor T cell linage
is characterised by expression of high levels of CD25 and CD4 [5],
while also expressing low levels of CD127 [6]. Natural Treg cells
constitutively express high levels of the T cell inhibitory receptor
cytotoxic T lymphocyte–associated molecule 4 (CTLA-4) [7] and
the glucocortcoid-inducible tumour necrosis factor receptor
(GITR) [8]. Forkhead box P3 (Foxp3) is the only transcription
factor required for generation of natural Treg cells [9] and it
constitutes the most specific marker for this cell population.
Natural Treg cells, initially identified by their capacity to inhibit the
development of autoimmune gastritis [10], are now known to
prevent other autoimmune conditions such as diabetes [7] and
inflammatory bowel disease [2,11], as well as inhibit anti-tumour
immunity [12]. They have been shown to inhibit both IL-2
production and cell proliferation of conventional CD4+ T
lymphocytes [13] by contact-dependent mechanisms and/or
through the production of anti-inflammatory cytokines such as
TGF-b [14] and IL-10 [15]. Although they have limited
proliferative capacity and are unable to secrete IL-2, natural Treg
cells exert their suppressive function after stimulation through the
T cell receptor, a process that appears to require antigen-
presenting cells [13]. After activation, natural Treg cells do no
require further stimulation and are able to suppress T cell
responses in a non-specific manner.
In addition to natural Treg cells, induced Treg cells constitute
another subset of suppressor lymphocytes [16]. Unlike naturally
occurring Treg cells, which develop in the thymus, induced Treg
cells are derived from conventional CD4+ T cells and acquire
suppressive activity upon activation and exposure to signals such as
immunosuppressive cytokines or immature dendritic cells (DCs).
Why Are Treg Cells Expected to Play a Role in
Malaria Infection?
Malaria is one the most serious infectious diseases of humans,
infecting 5%–10% of the world’s population, with approximately
500 million clinical cases annually. This infection is transmitted to
vertebrate hosts by the bite of female Anopheles mosquitos that are
infected with protozoan parasites of the genus Plasmodium.
Although there are several different species of Plasmodium parasites,
most cases of severe disease and fatalities are caused by the blood-
stage cycle of Plasmodium falciparum, which is endemic in sub-
Saharan Africa and throughout the tropics. The fatalities are
associated with a spectrum of discrete and overlapping disease
syndromes including acute respiratory distress, coagulopathy,
shock, metabolic acidosis, hypoglycaemia, renal failure, pulmo-
nary oedema, and cerebral involvement [17]. In endemic areas,
the most susceptible population to symptoms associated with
severe malaria are children under the age of 5 who have
experienced few parasitic infections. After many years of exposure,
individuals living in endemic areas develop clinical immunity to
disease, which is characterised by low parasitemia levels rather
Citation: Hansen DS, Schofield L (2010) Natural Regulatory T Cells in Malaria:
Host or Parasite Allies? PLoS Pathog 6(4): e1000771. doi:10.1371/journal.
ppat.1000771
Editor: Marianne Manchester, University of California San Diego, United States of
America
Published April 29, 2010
Copyright:  2010 Hansen, Schofield. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: The authors were supported by Grants # 406601, 516735 and 575538
from the National Health and Medical Research Council. LS is an International
Research Scholar of the Howard Hughes Medical Institute. The funders had no
role in the study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests
exist.
* E-mail: hansen@wehi.edu.au
PLoS Pathogens | www.plospathogens.org 1 April 2010 | Volume 6 | Issue 4 | e1000771
than sterilising immunity [18,19]. However, this clinical immunity
is known as ‘‘premunition’’, as it requires ongoing exposure to the
pathogen, and is lost quite rapidly in the absence of transmission.
The reason why malaria parasites persist under the state of
premunition is unknown, but it has been suggested that
immunosuppressive mechanisms able to modulate protective
immunity might lead to the persistence of parasites. In support
of this hypothesis, several immunosuppressive processes have been
described accompanying both human and experimental malaria
infections, including reduced T cell proliferative and IFN-c
responses to parasite antigens [20,21] and production of
immunosuppressive cytokines such as IL-10 [15,22] and TGF-b
[23]. As natural Treg cells have been shown to mediate their
suppressive effects through the production of these cytokines, it has
been tempting to postulate that this immunoregulatory lineage
could impede induction of immunity to malaria.
Although acquired host immunity limits the clinical impact of
malaria infection and provides protection against parasite
replication, experimental evidence indicates that cell-mediated
immune responses also result in detrimental inflammation and
contribute to induction of severe disease. In both P. falciparum
infections and rodent malaria models, severe disease syndromes
arise in diverse organs (e.g., brain, lungs, placenta) and appear to
result from the combined effect of cytoadherence of parasitised red
blood cells (pRBCs) in vascular beds and a strong host pro-
inflammatory response mediated by cytokines such as TNF-a [24],
LT-a [25], and IFN-c [26], and effector cells such as CD4 [27,28]
and CD8 T cells [29,30], natural killer (NK) T cells [31,32], and
NK cells [33]. As pro-inflammatory cytokines produced by these
cells upregulate the expression of adhesion molecules such as
intercellular cell adhesion molecule 1 (ICAM-1) [34], which is
involved in the recognition of parasitic proteins expressed on
pRBCs [35], it has been proposed that local and/or systemic
inflammatory cascades exacerbate parasite sequestration. Further-
more, emerging evidence from both human malaria and
experimental animal models [29,30,36,37] has revealed the
presence of leukocytes in blood vessels of inflamed tissue,
suggesting that in addition to their systemic effects, intravascular
infiltration of these cells might result in local inflammation and
could also contribute to disease induction. Thus, cell-mediated
immune responses appear to play a dual role in malaria: mediating
protective immunity on the one hand, and contributing to severe
inflammation and pathogenesis on the other. Whether natural Treg
cells are involved in promoting a balance between these processes
has been the subject of several studies. In this review we have
summarised the main findings to date investigating the role of
natural Treg cells during malaria, including experimental infection
using a variety of murine infection models as well as human field
studies. The implication of those findings for the induction of
pathogenesis and immunity to malaria is discussed.
Natural Treg Cells and the Control of Parasite
Clearance in Rodent Malaria Infection Models
Most of the studies using rodent models of infection have relied
on the use of anti-CD25 antibodies for in vivo depletion of natural
Treg cells (Table 1). Although this appears to be a standard
procedure to effectively deplete natural Treg cells in vivo, one
disadvantage of this approach is that CD25 is upregulated in
activated T cells, thus making it difficult to specifically target
natural Treg cells in experimental models in which conventional
lymphocytes are expected to become activated. This potential
confounder should be addressed experimentally or taken into
consideration for interpretation of experimental results.
Several studies have investigated whether natural Treg cells
modulate the induction of immune mechanisms responsible for the
control of parasite burden. Experimental infections with malaria
species such as Plasmodium chabaudi and Plasmodium yoelii are
particularly useful for addressing this question since they result in
high parasitemia levels and do not induce T cell–mediated organ-
specific disease syndromes (Table 2). There are two sub-strains of P.
yoelii 17X. One of them is highly virulent (PyL) and induces lethal
infections, whereas the other one (PyNL) results in a self-resolving
non-lethal infection. This difference in outcome suggested that
while infection with non-lethal parasites induces adaptive immune
responses able to limit parasite replication, immunosuppressive
mechanisms might operate when mice are infected with the lethal
sub-strain, preventing the induction of protective immunity. Two
independent studies have investigated whether natural Treg cells
play a role in the inhibition of immune responses against P. yoelii
17X. One found that depletion of natural Treg cells protects BALB/
c mice from overwhelming parasitemia and death after infection
with PyL parasites, raising the possibility that natural Treg cell
function provides an essential escape mechanism used by malaria
parasites to evade host-mediated immunity [38]. A subsequent
study found that Foxp3+ regulatory T cells expand and become
activated in response to infection with both PyL and PyNL
parasites. However, in vivo depletion experiments failed to
recapitulate the initial observations supporting a role for natural
Treg cells in the control of parasitemia levels [39]. Moreover, CD4
+
CD252 Foxp32CD1272 adaptive T cells and not natural Treg cells
were found to be the source of IL-10 responsible for downregulation
of protective immune responses during P. yoelii lethal infections [39].
The reasons for this inconsistency are unclear. The composition of
intestinal flora has been shown to influence the development of
natural Treg cells [40]. It is therefore possible that Treg cell depletion
in genetically identical mouse strains housed in various animal
facilities could lead to different infection outcomes if such mice differ
in the composition of bacteria in their gastrointestinal tract.
The impact of natural Treg cell depletion was also evaluated in
infection of mice with lethal (DS) and non-lethal (DK) strains of P.
chabaudi adami. Treg cell depletion resulted in increased production of
IFN-c and TNF-a in response to both lethal and non-lethal P.
chabaudi adami infection. In spite of the enhancement of pro-
inflammatory responses, Treg cell depletion did not alter the course
of infection in animals challenged with non-lethal parasites [41].
Curiously, Treg cell depletion was found to exacerbate parasite
burden and accelerate death in mice infected with the lethal DS
strain. The haemolytic anaemia that results from hyperparasitemia
was also enhanced in the absence of natural Treg cells. These studies
accord with the notion that in experimental models resulting in
parasitemia of high density, T helper cell 1 (TH1) responses are not
sufficient to control parasite burden, and consistently the Treg cell–
dependent modulation of pro-inflammatory responses is not critical
in determining infection outcome (Figure 1B).
The effect of natural Treg cell depletion with anti-CD25
antibody was also evaluated in immunised as well as naı¨ve
BALB/c mice after infection with P. berghei NK65. Treg cell
depletion resulted in a delay in the onset of parasitemia compared
to non-depleted controls [42]. Whether Treg cell depletion
influenced the development of immune responses involved in the
control of parasitemia was not investigated.
The Role of Natural Treg Cells in the Control of
Experimental Cerebral Malaria
Although infection of mice with P. yoelii, P. berghei NK65, and P.
chabaudi adami results in hyperparasitemia and death of susceptible
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mice due to haemolytic anaemia, it does not induce T cell–mediated
organ-specific immunopathology. Therefore, a contribution of Treg
cells to the control of pathogenic immune responses cannot be
accurately assessed in those infection models. In contrast, infection
of susceptible mouse strains with Plasmodium berghei-ANKA induces
cerebral malaria (Table 2). This murine infection has many features
in common with the human disease and is thus an accepted model
for certain important aspects of clinical malaria [43–46]. It
manifests an inflammatory cytokine–dependent encephalopathy
associated with upregulation of adhesion molecules on the cerebral
microvascular endothelium, which facilitates sequestration of
pRBCs and the resulting recruitment of inflammatory CXCR3+
leukocytes [33,47,48]. C57BL/6 mice, genetically predisposed
towards TH1-dominated responses [49], are susceptible to the
murine cerebral malaria syndrome, whereas BALB/c mice, with a
genetically determined bias towards TH2 responses, are resistant
[50]. Moreover, C57BL/6 and BALB/c mouse strains differ in the
expression of molecules encoded by a polymorphic genetic region
called the natural killer complex (NKC) [51], and it has been shown
that the differential expression of these receptors in NK cells and
CD1d-restricted NKT cells influences their immunological behav-
iour in response to malaria infection and accounts for the degree of
susceptibility to severe malaria [31,32]. C57BL/6 NKC alleles are
associated with disease susceptibility and the increased severity to
cerebral malaria is associated with a differential immune response to
infection, characterised by a significantly enhanced IFN-c produc-
tion [32,52]. Interestingly, anti-inflammatory cytokines such as
TGF-b and IL-10 have been found to regulate type-1 responses
during infection [23] and to play a protective role against P. berghei–
mediated cerebral malaria [22], respectively, suggesting that
resistance to disease could be associated with the development of
suppressive mechanisms aimed at directly inhibiting pathogenic
inflammatory responses. Specifically to test that proposition, we
investigated the induction of T cell responses in cerebral malaria–
resistant mouse strains. Our main results revealed that CD4+ T cells
from cerebral disease–resistant BALB/c mice display a strong
inhibition of cell proliferation and IL-2 secretion in response to both
parasite-specific and polyclonal stimuli and that natural Treg cells
appear to play a role in the inhibition of T cell function occurring
during infection [53]. Moreover, anti-CD25 depletion experiments
revealed that Treg cells also prevent the development of parasite-
specific TH1 memory cells involved in the induction of cerebral
malaria during a secondary parasitic challenge, demonstrating a
regulatory role for this cell population in the control of pathogenic
responses leading to fatal disease [53]. Interestingly, although the
lack of natural Treg cells during primary exposure to malaria
enhanced TH1 memory responses and increased disease severity
during re-infection, it also resulted in improved control of parasite
burden. Thus, the results support the notion that although TH1
Table 1. Effect of Treg cell depletion in the outcome of malaria in rodent infection models.
Parasite Mouse Strain Effect on Parasitemia Effect on Immune Responses Effect on Severe Disease Reference
P. yoelii 17X (PyL) BALB/c Reduction Increased parasite-specific
proliferation
Not determined [38]
P. yoelii 17X (PyNL) BALB/c No effect Not determined Not determined [38]
P. yoelii 17X (PyL) C57BL/6 No effect Not determined No effect [39]
P. yoelii 17X (PyL) BALB/c No effect Not determined No effect [39]
P. chabaudi adami DS BALB/c Increase Increased IFN-c and TNF-a
production
Increased haemolytic anaemia [41]
P. chabaudi adami DK BALB/c No effect Increased IFN-c and TNF-a
production
Increased haemolytic anaemia [41]
P. berghei NK65 BALB/c Delayed onset Not determined Not determined [42]
P. berghei-ANKA BALB/c Reduction upon
re-infection
Increased TH1 memory
responses
Increased cerebral malaria rates
upon re-infection
[53]
P. berghei-ANKA C57BL/6 Not determined Not determined Protection from cerebral malaria
when depletion was carried out 2
days before parasitic challenge. No
effect when depletion was carried
out 30 days before challenge.
[55]
P. berghei-ANKA C57BL/6 Reduction Enhanced T cell activation
and IFN-c responses
Protection from cerebral malaria when
depletion was carried out 2 and 14
days prior to parasitic challenge
[54]
P. berghei-ANKA CBA Reduction Not determined Protection from cerebral malaria when
depletion was carried out 14 days
prior to challenge
[56]
P. berghei-ANKA C57BL/6 No effect Enhanced T cell activation No effect [56]
doi:10.1371/journal.ppat.1000771.t001
Table 2. Malaria rodent models used to investigate Treg cell
function.
Lethal Infection Severe Immunopathology
BALB/c C57BL/6 BALB/c C57BL/6
P. yoelii 17X (PyL) Yes Yes No No
P. yoelii 17X (PyNL) No No No No
P. chabaudi adami (DS) Yes No No No
P. chabaudi adami (DK) No No No No
P. berghei NK65 Yes Yes No No
P. berghei-ANKA Yes Yes No Yes
doi:10.1371/journal.ppat.1000771.t002
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responses could be beneficial to control malaria re-infection, they
should be carefully regulated in order to prevent harmful
pathogenesis (Figure 1C).
Two independent studies investigated the effect of natural Treg
cell depletion with anti-CD25 antibody in the development of
cerebral malaria using the disease-susceptible C57BL/6 mouse
strain. Because both CD4 and CD8 T cells have been shown to
contribute to the induction of severe malaria in this mouse strain,
the use of anti-CD25 antibodies in Treg cell depletion protocols
requires careful experimental design to avoid targeting activated T
cells, which could confound interpretation of the results. Both
studies evaluated susceptibility rates of C57BL/6 mice that had
been depleted of natural Treg a day prior to infection with P.
berghei-ANKA [54,55]. Under these experimental conditions, anti-
CD25 injection resulted in complete protection from cerebral
malaria. To minimize depletion of parasite-specific activated T
Figure 1. Treg cells in malaria: Lessons learnt from experimental rodent models. (A) In murine models characterised by high pro-
inflammatory responses to infection, Treg cell depletion may result in a strong and rapid cellular immune response, which could rapidly control
parasitemia, in turn reducing parasite-mediated pathology. MØ, macrophage. (B) In an infection setting resulting in poor inflammatory responses to
malaria, a lack of Treg cells may improve the induction of such responses but at levels that are not sufficient to control parasite burden or induce
immunopathology. (C) In re-infection models, TH1 responses generated in the absence of Treg cells during primary exposure appear to be robust
enough to facilitate control of parasitemia in a secondary challenge at the expense of increased immune-mediated severe disease induction.
doi:10.1371/journal.ppat.1000771.g001
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cells that could be potentially involved in cerebral malaria
induction, both studies performed Treg cell depletion several
weeks prior to parasitic challenge. Whereas Treg cell depletion 30
days before challenge did not alter parasite burden and
susceptibility rates of C57BL/6 mice to cerebral malaria [55],
anti-CD25 treatment carried out 14 days before parasitic
challenge appeared to protect susceptible mice from fatality [54].
Similar results were obtained when natural Treg cells were
depleted under similar conditions in cerebral malaria–susceptible
CBA mice [56]. Protection from disease was associated with
reduced parasite burden and reduced sequestration of pRBCs in
brains of infected mice [54]. The increased resistance to infection
correlated with enhanced levels of T cell activation and IFN-c
production in spleens of P. berghei-ANKA-infected mice. These
latter data suggest that administration of anti-CD25 antibody does
not lead to significant depletion of activated antigen-specific T cells
in these experiments. However, a recent study shows that Treg cell
depletion in DEREG mice, which are transgenic for a bacterial
chromosome expressing a diphtheria toxin (DT) receptor–
enhanced GFP fusion protein under the control of the foxp3 locus
that allows for selective depletion of Foxp3+ Treg cells by DT
injection, did not alter the incidence of cerebral malaria after acute
P. bergei-ANKA infection [57].
Thus, the contribution of Treg cells to the induction of cerebral
malaria in the C57BL/6 background remains controversial. If a
role in acute responses is proven, it might be the case that strong
early IFN-c responses produced in the absence of Treg cells in
disease-susceptible C57BL/6 mice facilitate control of parasite
burden, resulting in reduced sequestration and protection from
cerebral malaria (Figure 1A). The magnitude of inflammatory
responses obtained after Treg cell depletion in disease-resistant
BALB/c animals (genetically predisposed to produce poor IFN-c
responses to malaria [52]) results in a more modest effect, which
only exacerbates disease severity but is not sufficient to control
parasitemia or increase fatality rates in a primary infection. In
cerebral malaria–resistant animals, the impact of Treg cell
depletion becomes evident after re-infection, as TH1 memory
responses generated in the absence of Treg cells during initial
exposure appear to be robust enough to control re-infection
despite increased cerebral malaria induction rates. These consid-
erations imply that natural Treg cell function could be either
beneficial or detrimental depending on the timing and magnitude
of pro-inflammatory responses to malaria and the genetic
background of the host.
Human Studies
A few studies have investigated the role of natural Treg cells in
human malaria (Table 3). The implementation of such human
studies is quite complex. A variety of different factors, including
study design, number of individuals recruited for the study cohort,
and use of fresh or cryopreserved samples may all have an impact
on the results. These variables should be taken into account when
assessing the relevance of conclusions arising from human disease
association studies.
Foxp3 mRNA expression levels as well as CD3+CD4+
CD25hiCD692 cell numbers were found to become highly
upregulated after experimental sporozoite infection of volunteers
via mosquito bites. Interestingly, individuals with a high
percentage of CD4+ Treg cells amongst their peripheral blood
mononuclear cells (PBMCs) were found to reach high parasite
densities earlier than those with low Treg cell frequencies,
suggesting that the presence of Treg cells in peripheral blood from
infected individuals might facilitate blood-stage parasite replica-
tion. Reduced production of the pro-inflammatory cytokines IFN-
c, IL6, and IL-12 as well as significantly enhanced production of
TGF-b levels were also found to be associated with high parasite
burden [58]. Interestingly, monocytes and not Treg cells were
found to be the cellular source of TGF-b produced in response to
infection. The authors proposed that monocyte-derived TGF-b
might favour Treg cell differentiation by inducing Foxp3
expression in naı¨ve peripheral CD4+ T lymphocytes. Increased
numbers of natural Treg cells would in turn downregulate pro-
inflammatory responses, which could result in enhanced parasite
growth [58].
The frequency of natural Treg cells was also investigated in
naturally infected individuals in a malaria-endemic region of
coastal Kenya. Multivariate analysis showed a significant associ-
ation between increased CD4+ CD25high numbers in peripheral
blood and increased risk of clinical malaria [59]. The majority of
Table 3. Association between natural Treg cells and the outcome of human malaria infections.
Population Expansion in Infection Association Immunosuppressive Activity Reference
Experimental sporozoite
infection of volunteers
Frequency of Treg cells
increased after experimental
exposure
Percentage of Treg cells in PBMCs
inversely correlated with onset of
high parasite density
Treg cells from infected volunteers were
found to inhibit in vitro proliferative
responses
[58]
Volunteers from Kenya Not determined Increased Treg cell numbers in
peripheral blood was associated with
increased risk of clinical malaria
Not determined [59]
Fulani and Mossi volunteers Percentage of Treg cells was
higher in Mossi than Fulani
individuals
High resistance to malaria in Fulani
individuals correlates with a
functional deficit of Treg cells
Lower immunosuppressive activity
in malaria-resistant Fulani individuals
[60]
Gambian children with severe
or uncomplicated malaria
Increased number of Treg cells
in severe and uncomplicated
malaria during convalescence
Frequency of Treg cells negatively
associated with the magnitude of
TH1 memory responses
Similar immunosuppressive function in
cases with severe and uncomplicated
malaria
[61]
Adult volunteers from Papua
with severe or uncomplicated
malaria
Increased number of Treg cell
in malaria patients relative to
asymptomatic controls
Treg cell frequency associated with
parasite biomass in severe but not
uncomplicated malaria cases
Severe malaria cases were characterised
by occurrence of a Treg cell subset
expressing high levels of TNFRII and Foxp3
with strong immunosuppressive function
[62]
Volunteers with acute P. vivax
infection in Thailand
Significant expansion during
acute infection
Not determined Not determined [65]
doi:10.1371/journal.ppat.1000771.t003
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CD4+ CD25high cells were found to express Foxp3, suggesting that
natural Treg cells may negatively affect natural acquired immunity
to malaria.
Interethnic comparative approaches on the susceptibility to
malaria performed in West Africa revealed that despite similar
levels of exposure, Fulani individuals appear to be more resistant
to P. falciparum malaria, as they display reduced parasitemia levels
and lower incidence of clinical episodes than other ethnic groups.
When the expression of genes involved in immune responses was
analysed in PBMCs of Fulani and sympatric Mossi individuals,
increased expression of TH1 (IFN-c, IL-18, TBX21) as well as
TH2-related genes (IL-4, IL-9, GATA3) was detected in the more
resistant Fulani individuals [60]. Interestingly, the upregulation of
immunity-associated genes correlated with reduced frequencies of
CD4+ CD25+ Foxp3+ cells in peripheral blood in Fulani compared
to Mossi individuals and reduced expression of Treg cell–related
products such as CTLA4 and TGF-b. Moreover, whereas in vitro
depletion of CD25+ cells enhanced proliferative responses to P.
falciparum antigens in PBMCs from Mossi individuals, Treg cell
depletion did not alter parasite-specific proliferation rates of the
Fulani, suggesting that a functional deficit of natural Treg cells
could be involved in the lower susceptibility to malaria of this
ethnic group [60].
The role of natural Treg cells in clinical malaria was investigated
in children with either severe or uncomplicated malaria [61]. TH1
responses were found to be more elevated in severe compared to
uncomplicated malaria cases. However, no significant differences
in the absolute number or the frequency of natural Treg cells were
detected between these two groups. Moreover, in vitro depletion
studies with anti-CD25 resulted in similarly increased cell
proliferation to schizont antigen in both severe and uncomplicated
malaria cases, suggesting that Treg cells from both groups of
patients have similar activity and implying that natural Treg cell
function is not sufficient to downregulate the strong TH1 response
to infection occurring in children with severe malaria. Interest-
ingly, high FOXP3 mRNA levels at base line were found to be
associated with reduced parasite-specific IFN-c memory responses
amongst PBMCs collected form convalescent malaria patients
[61]. This result resembles findings obtained in the P. berghei-
ANKA mouse model of severe malaria [47]. Whether Treg cells
acquired during a primary infection in human malaria are able to
modulate TH1 memory responses involved in parasite clearance
without inducing immunopathology requires further investigation.
The relationship between Treg cell function and parasite
biomass was evaluated in adults with uncomplicated or severe
malaria in an endemic area of West Papua [62]. Treg cell numbers
increased in malaria cases compared to non-infected controls,
indicating that these cells expand in response to infection. In
patients with severe but not uncomplicated malaria, Treg cell
frequency was correlated with parasite biomass. Phenotypic
characterization revealed that Treg cells from severe malaria cases
express high levels of TNFRII and constitute a subset of regulatory
cells that express high levels of Foxp3 and appear to exert strong
immunosuppressive function [62].
Recent in vitro studies using PBMCs from healthy donors
stimulated with P. falciparum–infected RBCs have provided
interesting insights into the mechanism by which Treg cells are
induced by malaria [63]. Stimulation with parasitised RBCs was
found to induce expansion of two Treg cell populations expressing
different levels of Foxp3. Only cells expressing intermediate
(Foxp3int) but not high (Foxp3hi) Foxp3 levels were found to
secrete large amounts of effector cytokines. Moreover, high
proportions of Foxp3hi cells in the co-culture systems correlated
with reduced production of pro-inflammatory cytokines, which
suggests that this subset plays a role in inhibition of parasite-
induced effector responses. Both malaria-elicited Treg subsets
appeared to be derived from conventional CD4+CD252Foxp32 T
cells. The parasite-driven upregulation of Foxp3 levels required
activated monocytes. However, soluble factors rather than direct
contact were found to be responsible for this process. These results
suggest a T cell receptor–independent mechanism for bystander
activation of CD4+CD25+Foxp3+ T cells during malaria.
Phenotypic characterization of Treg cells in PBMCs of healthy
Gambian donors ex vivo revealed a very heterogenous population
of Foxp3+ cells in this cohort study, with cells displaying different
expression levels of CD25 [64]. In vitro stimulation with crude
parasite extracts increased CD25 expression levels. The memory
phenotype of CD4+Foxp3+ T cells was also investigated using
expression of the chemokine receptors CCR7 and CCR4 to
identify central and effector memory cells, respectively [64]. Ex
vivo analysis indicated that antigen-experienced (CD45RO+)
Foxp3+ cells were predominantly effector memory cells. Moreover,
these cells were also found to express high levels of CD95
consistent with a highly pro-apoptotic phenotype.
Only one study has investigated whether Treg cells become
activated in response to Plasmodium vivax infection. Similar to
association studies in P. falciparum malaria, the percentage of
Foxp3+ Treg cells was found to increase in acute P. vivax infection.
In vitro elicitation assays confirmed this observation, as the
number of Foxp3+ cells amongst PBMCs significantly increases in
response to P. vivax antigens [65]. The relevance of these findings
in the context of P. vivax malaria needs to be further investigated.
Concluding Remarks
The current evidence from rodent infection models as well as
human studies suggests that the natural Treg cell pool becomes
activated and expands in response to malaria infection
[39,41,55,61,62,66]. Whether such expansion results from direct
proliferation, cytokine-driven differentiation, and/or recruitment
of natural Treg cells to secondary lymphoid organs is not
completely understood. In vitro studies provided evidence that
Treg cells proliferate in response to malarial antigens [62,65]. The
precise mechanism by which such antigens stimulate natural Treg
cells is still unclear. It has been shown that Treg cells express toll-
like receptors (TLRs) and proliferate in response to lipopolysac-
charide [67], raising the possibility that putative malarial TLR
agonists such as GPI [68,69,70] or hemozoin-bound DNA [71]
might stimulate Treg function during infection. Although it is not
known if these molecules can specifically stimulate proliferation
upon binding to natural Treg cell–expressing TLRs, a recent study
demonstrated that TLR9 engagement in DCs is required for
natural Treg cell activation by malaria parasites [72].
Although the available literature does not support a unified
model for the role of natural Treg cells in malaria, a common
feature emerging from data in experimental models and human
association studies appears to be the ability of this suppressive T
cell population to modulate acute pro-inflammatory and/or TH1
memory responses to infection. In animal models, the increased
inflammatory response resulting from natural Treg cell depletion
was not always sufficient to control parasitemia levels, particularly
in models of high parasite density in which antibody-mediated
responses are known to play an important role in protective
immunity. In low parasite density models, though, pro-inflamma-
tory responses generated in the absence of natural Treg cells
appeared to be more efficient in controlling acute infection,
leading to reduced organ-specific parasite sequestration. Consis-
tent with an immunoregulatory role in chronic conditions [73,74],
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evidence arising from rodent re-infection models [53] as well as
severe malaria association studies in humans [61] supports the
notion that natural Treg cells modulate parasite-specific TH1
memory rather than acute responses involved in disease induction,
suggesting that this cell population may limit the risk of immune-
mediated pathogenesis upon re-infection. On the other hand,
human studies available to date reveal associations between Treg
cell frequency and increased parasite densities, which in some
cases were found to correlate with increased severity of disease.
Overall, the literature suggests that whereas in some settings Treg
cells might modulate detrimental inflammation involved in disease
induction, in other cases Treg cell–mediated inhibition of immune
responses results in increased parasite density, which is also known
to be a key determinant of disease severity. As often in malaria, the
picture seems to be more complex than initially envisaged, and
whether natural Treg cell activation results in a favourable
outcome for the parasite or the host depends on a variety of
factors, including the timing and magnitude of such pro-
inflammatory responses to infection, the level of exposure to the
parasite, and the genetic background of the host.
The findings concerning the role of Treg cells in relation to
malaria infection thus appear consistent with the growing
literature on the role of Treg cells in other infectious diseases,
supporting the general view that these cells maintain homeostasis
by controlling the magnitude of immune responses. Broadly
speaking, in the context of other infectious diseases, Treg cells
curtail potent and sometimes over-vigorous effector responses. The
selective basis of this activity appears to be the need to limit the
significant tissue damage that can arise as a side-consequence of
antimicrobial immune responses. For example, reactive oxygen
species, while a powerful weapon against microbes, can cause
significant damage to the host. In certain circumstances, the need
to reduce or prevent serious tissue damage can compromise the
ability to control infection. Examples of the role of Treg in reducing
immunopathology can be found in the original observation of their
role in control of colitis [75], reduction of pulmonary inflamma-
tion in Pneumocystis [76], control of hepatic pathology in Schistosoma
infections [77] and control of immunopathological leasions in viral
infections [78], etc. The evidence for Treg cell–dependent control
of immune responses, leading sometimes to failure of the effector
arm, comes most clearly from studies on chronic infections e.g.,
Leishmania major [79]. One outcome of the counter-regulatory
activity against the effector response appears to be the promotion
of pathogen persistence, as exemplified by Litomosoides [80]. Treg
cells may thus play a crucial role in maintaining long-term,
balanced host/pathogen relationships, and hence in the promotion
of commensalism.
Future Directions
Future directions in Treg cell research of relevance to malaria
can be envisaged at several levels. Firstly, the activation of Treg cell
or their induction in the periphery appears to result from a wide
range of signals, including direct stimulation of TLR or other
pattern-recognition receptors, the maturation and activation of
DCs and other accessory cells by pathogens through similar
pathways, the cellular cytokine milieu and the potential contribu-
tion of parasite ligands with direct regulatory roles. For
mechanistic studies, much can be attempted with human and
murine cells in vitro, and in murine models in vivo, to analyse the
molecular signals of parasite origin leading to Treg cell activation,
and the other contributory cells of the immune system. Secondly,
as exemplified here, the contribution of Treg cells depends upon
the kinetics and dynamics of the infection, and much more needs
to be done in whole animal models of chronic or repeated
infection malaria infection, to test experimentally the contribution
of Treg to infection and disease processes during re-exposure.
Finally, activation of Treg cells urgently needs to be assessed in the
context of longitudinal cohort studies in human populations to
further test the association of Treg activation parameters with
respect to parasitological and pathophysiological outcome vari-
ables. Put together, these three avenues may be required to test the
proposition that malaria actively engages in Treg cell activation in
order to promote the survival of the pathogen.
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